Genetic Testing
Comprehensive Genetic & Biomarker Testing
Comprehensive genetic panels ranging from consumer-grade SNP arrays (23andMe, AncestryDNA) to clinical whole-exome and whole-genome sequencing (Dante Labs, Nebula Genomics), combined with advanced blood biomarker testing for preventive health optimization. Growing rapidly in the UAE with specialized clinics offering integrated genetic and metabolic profiling for longevity-focused individuals.
How Genetic Testing Works
Genetic testing analyses DNA — typically from saliva or blood — to identify variants (polymorphisms, mutations) in specific genes associated with disease risk, drug metabolism, nutrient processing, and other biological traits. Consumer tests typically genotype 500,000-2,000,000 single nucleotide polymorphisms (SNPs) using microarray chips, while clinical tests may use whole exome or whole genome sequencing. Risk scores are calculated using genome-wide association study (GWAS) data, combining the effects of multiple variants into polygenic risk scores that estimate relative disease probability compared to population averages.
📊 Evidence by Outcome
Polygenic risk scores can identify individuals at elevated risk for conditions like coronary artery disease, type 2 diabetes, and certain cancers. The Khera et al. 2018 study showed polygenic scores identify 8% of the population at threefold increased risk for coronary disease.
35 studies • Consistency: Moderate • Effect: Moderate
Genetic variants in drug-metabolizing enzymes (CYP450 family) reliably predict medication response and adverse reactions. Pharmacogenomic testing is one of the most clinically validated applications of genetic testing.
22 studies • Consistency: High • Effect: Moderate
While genetic information can theoretically guide personalized lifestyle changes, evidence that receiving genetic risk information leads to sustained behavior change is mixed. Motivation often fades without ongoing support.
14 studies • Consistency: Low • Effect: Small
Key Research
Peer-Reviewed Evidence • 4 Citations
ACMG recommendations for reporting of secondary findings in clinical exome and genome sequencing
Green RC, Berg JS, Grody WW, et al.•Genetics in Medicine•2013•PMID: 23788249
Key Finding: Established clinical framework for reporting actionable genetic findings, identifying 56 genes where pathogenic variants warrant medical intervention regardless of original testing indication.
View on PubMedGenome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
Khera AV, Chaffin M, Aragam KG, et al.•Nature Genetics•2018•PMID: 30104762
Key Finding: Polygenic risk scores identified 8% of the population at greater than threefold increased risk for coronary artery disease, comparable to risk conferred by rare monogenic mutations.
View on PubMedClinical use of current polygenic risk scores may exacerbate health disparities
Martin AR, Kanai M, Kamatani Y, et al.•Nature Genetics•2019•PMID: 30926966
Key Finding: Important caveat that most polygenic scores are derived from European-ancestry populations, with significantly reduced predictive accuracy in other populations including Middle Eastern and South Asian groups.
View on PubMedClinical Pharmacogenetics Implementation Consortium Guidelines
Caudle KE, Dunnenberger HM, Freimuth RR, et al.•Clinical Pharmacology & Therapeutics•2017•PMID: 27997040
Key Finding: Guidelines covering 20+ gene-drug pairs where pharmacogenomic testing has sufficient evidence to guide prescribing decisions, demonstrating one of the most mature clinical applications of genetic testing.
View on PubMedCitations sourced from PubMed, Cochrane Library, and peer-reviewed journals. Study findings are summarized for accessibility. Always consult the original publication for full methodology and results.
Side Effects & Safety
Interactions & Contraindications
Drug Interactions
- •Pharmacogenomic results may indicate need to adjust doses of antidepressants, blood thinners, statins, and pain medications
- •CYP450 enzyme variants affect metabolism of hundreds of common drugs
Supplement Interactions
- •MTHFR variants may indicate need for methylated B-vitamins instead of folic acid
- •COMT variants affect tolerance of methyl donors (SAMe, methylfolate)
- •VDR variants may affect vitamin D metabolism and dosing needs
Food & Timing
- •Lactase persistence gene determines dairy tolerance
- •ALDH2 variants affect alcohol metabolism and cancer risk
- •FTO gene variants influence appetite regulation and response to dietary interventions
Who Should Avoid
- •Individuals not psychologically prepared to receive potentially distressing genetic information
- •Minors (for adult-onset disease risk testing, by ethical convention)
- •Testing without access to genetic counselling for interpretation
📋 Protocol Snapshot
Protocols are for informational purposes only. Always consult a qualified healthcare provider before starting any treatment protocol.
Cost Guide
AED 400-6,000/test
Estimated UAE pricing. Costs vary by provider, dosage, and treatment plan.
Frequently Asked Questions
The UAE offers both consumer and clinical genetic testing. Consumer options include 23andMe and AncestryDNA (shipped internationally). Clinical services are available at facilities like the Centre for Arab Genomic Studies in Dubai, Cleveland Clinic Abu Dhabi, and multiple private genetics clinics. The UAE Genome Programme is also building population-level genomic resources. Costs range from AED 400 (consumer SNP panels) to AED 5,000+ (clinical whole exome sequencing).
The UAE has data protection regulations, but specific genetic non-discrimination laws similar to GINA (US) are still developing. Consider using clinical-grade testing through licensed healthcare facilities rather than consumer platforms for better data protection. Be cautious about uploading raw genetic data to third-party interpretation sites. Ask your provider about data storage, sharing policies, and deletion options.
Strongly recommended, especially for clinical-grade tests or if results reveal high-risk variants. Genetic counsellors help contextualise risk percentages, explain what results do and do not mean, and guide appropriate next steps. Many Dubai healthcare facilities offer genetic counselling services. Consumer test results for ancestry and basic traits are generally safe to interpret independently.
Not yet, despite marketing claims. While certain variants affect caffeine metabolism, lactose tolerance, and fat vs. carbohydrate processing, the overall predictive power for personalised nutrition is modest. Genetic testing is one useful data point among many (including blood work, microbiome, lifestyle factors). Beware of companies promising highly specific dietary plans based solely on DNA.
Where to Get It (UAE)
Related Treatments
Medical Disclaimer: The information on this page is for educational purposes only and is not intended as medical advice. Kamura Scores reflect a combination of research evidence, community data, and other factors — they are not clinical recommendations. Research citations are provided for reference; always consult the original publications for complete study details. Consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Individual results may vary.